Adventa Bioscience launches Trulacta human-milk supplement

15-Jul-2021 - Last updated on 15-Jul-2021 at 08:36 GMT

Trulacta is composed of thousands of components found in human milk. Pic: Adventa

Related tags HMOs HMO Breast milk immunoglobulin

Adventa Bioscience, a company dedicated to improving adult human health, has announced the launch of Trulacta, the world's first and only supplement made entirely of human milk.

Adventa has utilized advanced science and proprietary technology to create a supplement containing human milk bionutrients (HMBs), which the company said have been shown to support whole-body health.

Trulacta is composed of thousands of components found in human milk. The supplement's HMBs include human milk oligosaccharides (HMO), growth factors, immunoglobulins, macrophages and stem cells, as well as other enzymes and peptides. Adventa said the combination of the compounds has shown to aid the development of the immune system, protect from autoimmune disease, actively fight bacteria and allow the body to maintain and restore itself.

"All human bodies are made to recognize, accept and thrive on human milk bionutrients," said Peter Lamb, COO of Adventa Bioscience.

"Over 70% of the immune system resides in the gut and Trulacta is designed to support gut health while positively impacting overall immune health in ways that probiotics and prebiotics can't. Studies have shown a healthy gut can improve mental health, optimize digestion and lead to a more restful sleep."

75% of adults deal with gastrointestinal issues that range from ulcerative colitis to irritable bowel syndrome to Crohn's disease. Many others suffer from poor sleep, compromised immunity and anxiety.

"The advances in research and technology, as well as the significant progress in product development that we are making at Adventa, are providing hope and restoring lives," Lamb said.

Adventa conducted a limited pre-clinical study in fall 2020 with 84% of participants reporting positive results with regards to relief of gastrointestinal symptomatology as well as other inflammatory issues. Improvements in restless sleep, headaches and joint pain were also reported and may be explained by Trulacta's positive impact on neurotransmitters and inflammation. Because of these positive findings, Adventa is initiating full-scale clinical testing to begin by August 2021.

"Human milk is the natural powerhouse required for the healthy growth of humans at the most critical period of our lives," said Dr Daniel Crisafi, ND.A., Ph.D.

"Trulacta has now made it possible for adults to benefit from the precious nutrients and nutraceuticals in human milk to help support whole-body health."